Cargando…
Stem cell-derived intestinal organoids: a novel modality for IBD
The organoids represent one of the greatest revolutions in the biomedical field in the past decade. This three-dimensional (3D) micro-organ cultured in vitro has a structure highly similar to that of the tissue and organ. Using the regeneration ability of stem cells, a 3D organ-like structure called...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362068/ https://www.ncbi.nlm.nih.gov/pubmed/37479716 http://dx.doi.org/10.1038/s41420-023-01556-1 |
_version_ | 1785076341212708864 |
---|---|
author | Tian, Cheng-mei Yang, Mei-feng Xu, Hao-ming Zhu, Min-zheng Yue, Ning-Ning Zhang, Yuan Shi, Rui-yue Yao, Jun Wang, Li-sheng Liang, Yu-jie Li, De-feng |
author_facet | Tian, Cheng-mei Yang, Mei-feng Xu, Hao-ming Zhu, Min-zheng Yue, Ning-Ning Zhang, Yuan Shi, Rui-yue Yao, Jun Wang, Li-sheng Liang, Yu-jie Li, De-feng |
author_sort | Tian, Cheng-mei |
collection | PubMed |
description | The organoids represent one of the greatest revolutions in the biomedical field in the past decade. This three-dimensional (3D) micro-organ cultured in vitro has a structure highly similar to that of the tissue and organ. Using the regeneration ability of stem cells, a 3D organ-like structure called intestinal organoids is established, which can mimic the characteristics of real intestinal organs, including morphology, function, and personalized response to specific stimuli. Here, we discuss current stem cell-based organ-like 3D intestinal models, including understanding the molecular pathophysiology, high-throughput screening drugs, drug efficacy testing, toxicological evaluation, and organ-based regeneration of inflammatory bowel disease (IBD). We summarize the advances and limitations of the state-of-the-art reconstruction platforms for intestinal organoids. The challenges, advantages, and prospects of intestinal organs as an in vitro model system for precision medicine are also discussed. [Figure: see text] |
format | Online Article Text |
id | pubmed-10362068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103620682023-07-23 Stem cell-derived intestinal organoids: a novel modality for IBD Tian, Cheng-mei Yang, Mei-feng Xu, Hao-ming Zhu, Min-zheng Yue, Ning-Ning Zhang, Yuan Shi, Rui-yue Yao, Jun Wang, Li-sheng Liang, Yu-jie Li, De-feng Cell Death Discov Review Article The organoids represent one of the greatest revolutions in the biomedical field in the past decade. This three-dimensional (3D) micro-organ cultured in vitro has a structure highly similar to that of the tissue and organ. Using the regeneration ability of stem cells, a 3D organ-like structure called intestinal organoids is established, which can mimic the characteristics of real intestinal organs, including morphology, function, and personalized response to specific stimuli. Here, we discuss current stem cell-based organ-like 3D intestinal models, including understanding the molecular pathophysiology, high-throughput screening drugs, drug efficacy testing, toxicological evaluation, and organ-based regeneration of inflammatory bowel disease (IBD). We summarize the advances and limitations of the state-of-the-art reconstruction platforms for intestinal organoids. The challenges, advantages, and prospects of intestinal organs as an in vitro model system for precision medicine are also discussed. [Figure: see text] Nature Publishing Group UK 2023-07-21 /pmc/articles/PMC10362068/ /pubmed/37479716 http://dx.doi.org/10.1038/s41420-023-01556-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Tian, Cheng-mei Yang, Mei-feng Xu, Hao-ming Zhu, Min-zheng Yue, Ning-Ning Zhang, Yuan Shi, Rui-yue Yao, Jun Wang, Li-sheng Liang, Yu-jie Li, De-feng Stem cell-derived intestinal organoids: a novel modality for IBD |
title | Stem cell-derived intestinal organoids: a novel modality for IBD |
title_full | Stem cell-derived intestinal organoids: a novel modality for IBD |
title_fullStr | Stem cell-derived intestinal organoids: a novel modality for IBD |
title_full_unstemmed | Stem cell-derived intestinal organoids: a novel modality for IBD |
title_short | Stem cell-derived intestinal organoids: a novel modality for IBD |
title_sort | stem cell-derived intestinal organoids: a novel modality for ibd |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362068/ https://www.ncbi.nlm.nih.gov/pubmed/37479716 http://dx.doi.org/10.1038/s41420-023-01556-1 |
work_keys_str_mv | AT tianchengmei stemcellderivedintestinalorganoidsanovelmodalityforibd AT yangmeifeng stemcellderivedintestinalorganoidsanovelmodalityforibd AT xuhaoming stemcellderivedintestinalorganoidsanovelmodalityforibd AT zhuminzheng stemcellderivedintestinalorganoidsanovelmodalityforibd AT yueningning stemcellderivedintestinalorganoidsanovelmodalityforibd AT zhangyuan stemcellderivedintestinalorganoidsanovelmodalityforibd AT shiruiyue stemcellderivedintestinalorganoidsanovelmodalityforibd AT yaojun stemcellderivedintestinalorganoidsanovelmodalityforibd AT wanglisheng stemcellderivedintestinalorganoidsanovelmodalityforibd AT liangyujie stemcellderivedintestinalorganoidsanovelmodalityforibd AT lidefeng stemcellderivedintestinalorganoidsanovelmodalityforibd |